Phase II study of weekly dose-intensified cisplatin chemotherapy with oral etoposide in recurrent glioma

Journal of Neuro-Oncology

Volumn 44, Issue 1, 1999, Pages 59-64

  Van Den Bent, M J ^a   Pronk, L ^b   Sillevis Smitt, P A E ^b   Vecht, Ch J ^b   Eskens, F A L M ^b   Verweij, J ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

Astrocytoma; Chemotherapy; Cisplatin; Etoposide; Glioma; Recurrent

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; ETOPOSIDE;

ADULT; ARTICLE; CANCER RECURRENCE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; FEMALE; GLIOMA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; MALE; NAUSEA; NEPHROTOXICITY; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; ORAL DRUG ADMINISTRATION; PHASE 2 CLINICAL TRIAL; THROMBOCYTOPENIA; TREATMENT OUTCOME; VOMITING;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; ETOPOSIDE; FEMALE; GLIOMA; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL;

EID: 0032741955     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006201909435     Document Type: Article

References (17)

1. Jeremic B, Grujicic D, Jevremovic S, Stanisavljevic B, Milojevic L, Djuric L, Mijatovic L: Carboplatin and etoposide chemotherapy regimen for recurrent malignant glioma: A phase II study. J Clin Oncol 10: 1074-1077, 1992
2. Ameri A, Poisson M, Chauveinc L, Chen QM, Delattre JY: Treatment of carboplatin and etoposide: A phase II study. J Neuro-Oncol 32: 155-160, 1997
3. Buckner LC, Brown LD, Cascino TL, Gerstner JB, Krook JE, Westberg MW, Wiesenfeld M, O'Fallon JR, Scheithauer B: Phase II evaluation of infusional etoposide and cisplatin in patients with recurrent astrocytoma. J NeuroOncol 9: 249-254, 1990
4. Tirelli U, D'Incalci M, Canetta R, Tumola S, Franchin G, Veronesi A, Galligioni E, Trovo MG, Rossi C, Grigoletto E: Etoposide (VP-16-213) in malignant brain tumors: A phase II study. J Clin Oncol 2: 432-437, 1984
5. Fulton D, Urtasun R, Forsyth P: Phase II study of prolonged oral therapy with etoposide (UP-16) for patients with recurrent malignant glioma. J Neuro-Oncol 27: 149-155, 1996
6. Warnick RE, Prados MD, Mack EE, Chandler KL, Doz F, Rabbitt JE, Malec MK: A phase JJ study of intravenous carboplatin for the treatment of recurrent gliomas. J Neuro-Oncol 19: 69-74, 1994
7. Prados MD, Warnick RE, Mack EE, Chandler KL, Rabbitt J, Page M, Malec M: Intravenous carboplatin for recurrent gliomas. Amer J Clin Oncol (CCT) 19: 609-612, 1996
8. Spence AM, Berger MS, Livingston RB, Ali-Osman F, Griffin B: Phase II evaluation of high-dose intravenous cisplatin for the treatment of adult malignant gliomas recurrent after chloroethylnitrosurea failure. J Neuro-Oncol 12: 187-191, 1992
9. Planting AST, Van der Burg MEL, de Boer-Dennert M, Stoter G, Verweij J: Phase I study of weekly high dose cisplatin combined with long term oral etoposide in advanced solid tumors. Ann Oncol 6: 190-192, 1994
10. Planting AST, Van der Burg MEL, Goey SH, Schellens JHM, Van den Bent MJ, de Boer-Dennert M, Stoter G, Verweij J: Phase II study of a short course of weekly high-dose cisplatin combined with long-term oral etoposide in pleural mesothelioma. Ann Oncol 6: 613-615, 1995
11. Planting AST, Kho GS, Van der Burg MEL, Goey SH, Schellens JHM, Van den Bent MJ, Van der Gaast A, de Boer-Dennert M, Stoter G, Verweij J: A phase II study of weekly high-dose cisplatin combined with oral etoposide in advanced non-small cell lung cancer. Cancer Chemother Pharmacol 40: 347-352, 1997
12. Planting AST, Van der Burg MEL, Van den Bent MJ, de Boer-Dennert M, Stoter G, Verweij J: Phase II study of as short course of weekly high-dose cisplatin combined with oral etoposide in metastatic colorectal carcinoma. Brit J Cancer 73: 1265-1267, 1996
13. Walker RW, Cairncross JG, Posner JB: Cerebral herniation in patients receiving cisplatin. J Neuro-Oncol 6: 61-65, 1988
14. Hildebrand J, De Witte O, Sahmoud T: Response of recurrent glioblastoma and anaplastic astrocytoma to dibromodulcitol, BCNU and procarbazine. J Neuro-Oncol 37: 155-160, 1998
15. Levin V, Yung A, Prados M, Poisson M, Rosenfeld S, Brada M, Friedman H, Albright R, Olson J, Bruner J, Yue N, Dugan M: Phase II study of temodal (temozolomide) at first relapse in anaplastic astrocytoma (AA) patients. J Neuro-Oncol 35: 185, 1997 (abstract)
16. Yung A, Albright R, Olson J, Frederick R, Fink D, Prados M, Brada M, Spence AM, Bruner J, Yue N, Dugan M: Randomized trial of temodal versusprocarbazine in glioblastoma multiforme at first relapse. J Neuro-Oncol 39: 102, 1998 (abstract)
17. Sanson M, Ameri A, Monjour A, Sahmoud T, Ronchin P, Poisson M, Delattre JY: Treatment of recurrent malignant supratentorial gliomas with ifosfamide, carboplatin and etoposide: A phase II study. Eur J Cancer 32A: 2229-2235, 1996